ClinicalTrials.gg
CompletedNCT00411216Updated Aug 7, 2015Results posted

Recovery of Visual Acuity in People With Vestibular Deficits

An interventional study of Control exercises and gaze stabilization exercises in Vestibular Neuronitis, Vestibular Neuronitis, Bilateral and Vestibular Schwannoma, sponsored by Emory University. Completed at 1 site in United States. Open to participants aged 18 Years to 80 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2015-08-07.

Sponsored by Emory University · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
23
Allocation
Randomized
Ages
18 Years to 80 Years
Sex
All
01

Study summary

The purpose of this study is to determine whether exercises relieve the symptoms of dizziness and imbalance in people with vestibular deficits and improves the ability to see clearly during head movements. We hypothesize that the performance of specific adaptation and substitution exercises will result in an improvement in visual acuity during head movements while those patients performing placebo exercises will show no improvement.

Read the detailed description

Decrements in visual acuity during head movement in patients with vestibular hypofunction are potentially serious problems. This deficit could contribute to decreased activity level, avoidance of driving with resultant diminished independence and, ultimately, limited social interactions and increased isolation. Oscillopsia occurs because of inadequate vestibulo-ocular reflex (VOR) gain and suggests that compensation for the vestibular loss has not occurred. The purpose of this study was to examine the effect of an exercise intervention on visual acuity during head movement in patients with unilateral and bilateral vestibular hypofunction. We hypothesized that 1) patients performing vestibular exercises would have improved visual acuity during head movement compared to patients performing placebo exercises; 2) there would be no correlation between dynamic visual acuity (DVA) and the patients' subjective complaints of oscillopsia; and 3) improvement in DVA would be reflected by changes in residual vestibular function as indicated by an increase in VOR gain.

Patients are assigned randomly to either the vestibular exercise or placebo exercise group. The randomization schedule is generated using a computer program for 2-sample randomization. The sequence was not concealed from the investigator who obtained consent from the subjects and supervised the exercises (SJH). The group assignment (vestibular exercise or placebo exercise) was concealed from the participants and from the investigator who performed the outcome measures.

The vestibular exercise group practiced exercises that consisted of adaptation exercises and eye-head exercises to targets (Table 1), which were designed to improve gaze stability 16. They also performed gait and balance exercises. The placebo exercise group performed exercises designed to be 'vestibular-neutral'.

02

Conditions studied

  • Vestibular Neuronitis
  • Vestibular Neuronitis, Bilateral
  • Vestibular Schwannoma

Keywords

  • vestibular rehabilitation
  • vestibular hypofunction
03

In context

Vestibular Neuronitis

34 studies on the registry are indexed under Vestibular Neuronitis; 4 are open to participants now.

This study's enrollment of 23 is below the median of 50 across 27 interventional studies indexed under Vestibular Neuronitis.

Browse Vestibular Neuronitis studies →

Lead sponsor

Emory University is the lead sponsor of 1,405 studies on the registry; 225 are open to participants now.

Of its 237 completed or terminated interventional studies of FDA-regulated products, 178 (75%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patient had to have either a unilateral vestibular or bilateral vestibular hypofunction defined as follows: Unilateral vestibular deficits were defined by a > 25% difference in slow phase eye velocity between right and left sides on either the caloric or rotary chair test. Bilateral vestibular deficits were defined included refixation saccades made in response to unpredictable head thrusts to the right and left, a gain \< .1 on rotary chair step test and a peak slow phase eye movement of \<5 degrees/sec during irrigation of each ear on bithermal water caloric testing
  • Healthy subjects with normal vestibular function test results
  • must be able to complete DVA test

Exclusion criteria

Exclusion Criteria:

  • Patients with central lesions will be omitted from the study because vestibular adaptation or other compensatory mechanisms may be compromised and
  • Patients with visual acuity when the head is stationary of 20/60 or worse.
  • Patients on medication that suppress or facilitate vestibular function will not be excluded from the study but data will be analyzed to assess the effect of medication.
  • Patient who do not understand the purpose of the study and what it involves
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
23 participants (actual)

Study arms

  • Experimental
    exercises for gaze stabilization

    Experimental group performed vestibular adaptation and substitution exercises

    Other: gaze stabilization exercises

  • Placebo comparator
    Control exercises

    Saccadic eye movements against a Ganzfeld to prevent retinal slip error signal; no head movements

    Other: Control exercises

Interventions

  • OtherControl exercises

    saccadic eye movements against a plain background; no head movements

  • Othergaze stabilization exercises

    adaptation and substitutin exercises encorporating retinal lsip and head movements

06

What researchers measure

Primary outcomes

  1. Change in Visual Acuity During Head Movement From Baseline to Discharge

    visual acuity is measured using a computerized system first with the head stationary and then with the head moving in yaw plane. Head velocity is measured using a rate sensor and optotype is displayed only when head velocity is between 120 and 180 degrees per second. The change in visual acuity was calculated from subtracting the discharge measurement from the baseline measurement (pre-intervention).

    Time frame: pre-intervention and at discharge

  2. Subjective Complaints: (All Pre- and Post-intervention):

    questionnaire

    Time frame: pre-intervention, 2 weeks, 4 weeks and at discharge

Secondary outcomes

  1. Disability Scale

    questionnaire

    Time frame: pre-intervention, 2 weeks, 4 weeks and at discharge

  2. Activities Specific Balance Confidence Scale

    questionnaire

    Time frame: pre-intervention, 2 weeks, 4 weeks and at discharge

  3. Symptoms Intensity for Dizziness, Oscillopsia, Disequilibrium

    visual analoque scales

    Time frame: pre-intervention, 2 weeks, 4 weeks and at discharge

  4. Balance and Gait

    gait speed

    Time frame: pre-intervention, 2 weeks, 4 weeks and at discharge

  5. Fall Risk (Dynamic Gait Index)

    performance test

    Time frame: pre-intervention, 2 weeks, 4 weeks and at discharge

  6. Eye Movements: Scleral Search Coil

    eye movements are measured by having the participant sit within an electromagnetic field while wearing a scleral coil (like a contact lens but only in contact with the sclea, not the cornea); te coil moves with eye movement and distorts the electrimagnetic field

    Time frame: pre- and post-treatment

07

Results

Posted Jul 21, 2014

Participant flow

Participant flow — Overall Study
MilestoneExercises for Gaze StabilizationControl Exercises
Started1310
Completed138
Not completed02
Withdrew: Ten participants were entered into the c02

Outcome measures

PrimaryChange in Visual Acuity During Head Movement From Baseline to Discharge

visual acuity is measured using a computerized system first with the head stationary and then with the head moving in yaw plane. Head velocity is measured using a rate sensor and optotype is displayed only when head velocity is between 120 and 180 degrees per second. The change in visual acuity was calculated from subtracting the discharge measurement from the baseline measurement (pre-intervention).

Time frame:
pre-intervention and at discharge
Reported as:
Mean · LogMAR
Change in Visual Acuity During Head Movement From Baseline to Discharge
LogMARExercises for Gaze StabilizationControl Exercises
Change in Visual Acuity During Head Movement From Baseline to Discharge0.198 ± 0.101.296 ± .122
PrimarySubjective Complaints: (All Pre- and Post-intervention):

questionnaire

Time frame:
pre-intervention, 2 weeks, 4 weeks and at discharge

Results for this outcome have not been posted.

SecondaryDisability Scale

questionnaire

Time frame:
pre-intervention, 2 weeks, 4 weeks and at discharge

Results for this outcome have not been posted.

SecondaryActivities Specific Balance Confidence Scale

questionnaire

Time frame:
pre-intervention, 2 weeks, 4 weeks and at discharge

Results for this outcome have not been posted.

SecondarySymptoms Intensity for Dizziness, Oscillopsia, Disequilibrium

visual analoque scales

Time frame:
pre-intervention, 2 weeks, 4 weeks and at discharge

Results for this outcome have not been posted.

SecondaryBalance and Gait

gait speed

Time frame:
pre-intervention, 2 weeks, 4 weeks and at discharge

Results for this outcome have not been posted.

SecondaryFall Risk (Dynamic Gait Index)

performance test

Time frame:
pre-intervention, 2 weeks, 4 weeks and at discharge

Results for this outcome have not been posted.

SecondaryEye Movements: Scleral Search Coil

eye movements are measured by having the participant sit within an electromagnetic field while wearing a scleral coil (like a contact lens but only in contact with the sclea, not the cornea); te coil moves with eye movement and distorts the electrimagnetic field

Time frame:
pre- and post-treatment

Results for this outcome have not been posted.

Adverse events

Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Exercises for Gaze Stabilization—0/13 (0%)0/13 (0%)
Control Exercises—0/8 (0%)0/8 (0%)
Most frequent other events
Most frequent other events
EventExercises for Gaze StabilizationControl Exercises
fallsNervous system disorders0/130/8

Baseline characteristics

Age, Continuous
Age, Continuous(years)Exercises for Gaze StabilizationControl ExercisesTotal
Mean65.2 ± 16.564.9 ± 16.265.1 ± 16.3
Age, Categorical
Age, Categorical(Participants)Exercises for Gaze StabilizationControl ExercisesTotal
<=18 years000
Between 18 and 65 years6511
>=65 years7512
Sex: Female, Male
Sex: Female, Male(Participants)Exercises for Gaze StabilizationControl ExercisesTotal
Female9615
Male448
Region of Enrollment
Region of Enrollment(participants)Exercises for Gaze StabilizationControl ExercisesTotal
United States131023
Visual acuity during head movements
Visual acuity during head movements(LogMAR)Exercises for Gaze StabilizationControl ExercisesTotal
Mean.372 ± .155.323 ± .117.348 ± .136
08

Study locations

1 site
  • Center for Rehabilitation Medicine, Emory University
    Atlanta, Georgia 30322, United States
09

References and documents

Publications

  • Herdman SJ, Tusa RJ, Blatt P, Suzuki A, Venuto PJ, Roberts D. Computerized dynamic visual acuity test in the assessment of vestibular deficits. Am J Otol. 1998 Nov;19(6):790-6. PubMed 9831156 ↗
  • Herdman SJ, Schubert MC, Tusa RJ. Role of central preprogramming in dynamic visual acuity with vestibular loss. Arch Otolaryngol Head Neck Surg. 2001 Oct;127(10):1205-10. doi: 10.1001/archotol.127.10.1205. PubMed 11587600 ↗
  • Schubert MC, Herdman SJ, Tusa RJ. Functional measure of gaze stability in patients with vestibular hypofunction. Ann N Y Acad Sci. 2001 Oct;942:490-1. doi: 10.1111/j.1749-6632.2001.tb03777.x. No abstract available. PubMed 11710496 ↗
  • Schubert MC, Herdman SJ, Tusa RJ. Vertical dynamic visual acuity in normal subjects and patients with vestibular hypofunction. Otol Neurotol. 2002 May;23(3):372-7. doi: 10.1097/00129492-200205000-00025. PubMed 11981398 ↗
  • Herdman SJ, Schubert MC, Das VE, Tusa RJ. Recovery of dynamic visual acuity in unilateral vestibular hypofunction. Arch Otolaryngol Head Neck Surg. 2003 Aug;129(8):819-24. doi: 10.1001/archotol.129.8.819. PubMed 12925338 ↗
  • Schubert MC, Das V, Tusa RJ, Herdman SJ. Cervico-ocular reflex in normal subjects and patients with unilateral vestibular hypofunction. Otol Neurotol. 2004 Jan;25(1):65-71. doi: 10.1097/00129492-200401000-00013. PubMed 14724495 ↗
  • Hall CD, Schubert MC, Herdman SJ. Prediction of fall risk reduction as measured by dynamic gait index in individuals with unilateral vestibular hypofunction. Otol Neurotol. 2004 Sep;25(5):746-51. doi: 10.1097/00129492-200409000-00017. PubMed 15354006 ↗
  • Herdman SJ, Hall CD, Schubert MC, Das VE, Tusa RJ. Recovery of dynamic visual acuity in bilateral vestibular hypofunction. Arch Otolaryngol Head Neck Surg. 2007 Apr;133(4):383-9. doi: 10.1001/archotol.133.4.383. PubMed 17438254 ↗
10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 7, 2015, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT00411216
Lead sponsor
Emory University
Responsible party
Susan Herdman (Professor, Emory University) — Principal investigator
First posted
Dec 13, 2006
Start date
Aug 2000
Primary completion
Dec 2004
Completion
Dec 2004
Results posted
Jul 21, 2014
Last update
Aug 7, 2015

Study contacts

Susan J Herdman, PhD
principal investigator · Emory University

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2015. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion